Tolerability and beneficial effects of sacubitril/valsartan on systemic right ventricular failure

Conclusions
Treatment with sacubitril/valsartan was associated with a low rate of adverse effects in this adult sRV cohort. Persisting improvement in 6-minute walking test distance, NT-proBNP levels and echocardiographic parameters of sRV function was observed in an on-treatment analysis and showed no differential response based on sex or anatomy.

Source: Heart - September 28, 2023 Category: Cardiology Authors: Nederend, M., Kies, P., Regeer, M. V., Vliegen, H. W., Mertens, B. J., Robbers-Visser, D., Bouma, B. J., Tops, L. F., Schalij, M. J., Jongbloed, M. R. M., Egorova, A. D. Tags: Congenital heart disease Source Type: research